Insider: Peetz Christopher CHIEF EXECUTIVE OFFICER - Mirum Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 194,309 | 201,570 | 395,879 |
| Value | $18,385,517.58 | $19,072,553.40 | $37,458,070.98 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/16/2026 | DDS | 40,985 | Direct | COM | $91.98 | $3,769,714.23 | 194,309 |
| 02/02/2026 | DDS | 9,108 | Direct | COM | $103.30 | $940,888.28 | 160,294 |
| 01/26/2026 | DDS | 6,831 | Direct | COM | $96.19 | $657,087.55 | 169,402 |
| 01/22/2026 | DDS | 7,098 | Direct | COM | $93.33 | $662,422.27 | 163,733 |
| 08/11/2025 | DDS | 40,000 | Direct | COM | $62.00 | $2,480,000.00 | 138,641 |
| 08/07/2025 | DDS | 40,000 | Direct | COM | $55.25 | $2,210,040.00 | 138,641 |
| 03/17/2025 | DDS | 27,279 | Direct | COM | $44.21 | $1,206,121.89 | 138,641 |
| 03/03/2025 | DDS | 19,392 | Direct | COM | $46.61 | $903,861.12 | 136,528 |
| 03/03/2025 | DDS | 20,608 | Direct | COM | $47.19 | $972,491.52 | 115,920 |
| 02/03/2025 | DDS | 9,102 | Direct | COM | $48.22 | $438,921.20 | 115,920 |
| 01/24/2025 | DDS | 6,837 | Direct | COM | $47.92 | $327,658.44 | 125,022 |
| 01/07/2025 | DDS | 7,489 | Direct | COM | $42.82 | $320,643.78 | 119,359 |
| 02/02/2024 | DDS | 6,013 | Direct | COM | $26.19 | $157,491.29 | 104,112 |
| 01/08/2024 | DDS | 5,209 | Direct | COM | $28.03 | $146,033.27 | 110,125 |
| 07/03/2023 | DDS | 5,498 | Direct | COM | $25.65 | $141,005.01 | 115,334 |
| 01/09/2023 | DDS | 5,159 | Direct | COM | $20.62 | $106,390.45 | 91,953 |
| 11/24/2021 | AAP | 7,000 | Direct | COM | $14.40 | $100,800.00 | 28,027 |
| 10/01/2021 | DDS | 3,672 | Direct | COM | $19.26 | $70,708.03 | 21,027 |
| 12/23/2020 | AAP | 2,000 | Indirect | COM | $18.60 | $37,200.00 | 201,570 |
| 12/23/2020 | AAP | 3,000 | Indirect | COM | $18.76 | $56,280.00 | 199,570 |
| 09/09/2019 | AAP | 2,000 | Indirect | COM | $10.90 | $21,800.00 | 194,250 |
| 09/09/2019 | AAP | 2,320 | Indirect | COM | $11.35 | $26,332.00 | 196,570 |
| 09/06/2019 | AAP | 4,750 | Indirect | COM | $10.91 | $51,805.88 | 192,250 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research